Channel Therapeutics Corp
CHRO1.350USD
+0.090+7.14%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
8.35MMarket Cap
LossP/E TTM
Channel Therapeutics Corp
1.350
+0.090+7.14%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Operating expenses
-5.17%1.83M
-52.95%1.83M
58.57%2.05M
126.99%1.76M
111.46%1.93M
456.52%3.88M
24.60%1.29M
161.97%777.16K
217.73%914.58K
231.94%696.98K
462.60%1.04M
--296.65K
--287.85K
--209.97K
--184.26K
R&D expenses
-58.36%194.30K
-87.57%285.24K
743.93%414.64K
-74.07%12.96K
150.71%466.61K
678.80%2.29M
75.59%49.13K
87.99%49.95K
336.97%186.12K
390.50%294.58K
-13.14%27.98K
--26.57K
--42.59K
--60.06K
--32.21K
Operating profit
5.17%-1.83M
52.95%-1.83M
-58.57%-2.05M
-126.99%-1.76M
-111.46%-1.93M
-456.52%-3.88M
-24.60%-1.29M
-161.97%-777.16K
-217.73%-914.58K
-231.94%-696.98K
-462.60%-1.04M
---296.65K
---287.85K
---209.97K
---184.26K
Net non-operating interest income (expenses)
Non-operating interest income
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
Non-operating interest expense
-78.73%133.63K
-32.66%107.97K
-69.99%39.02K
-93.72%11.06K
1108.87%628.35K
276.27%160.34K
243.82%130.01K
371.08%176.19K
129.94%51.98K
--42.61K
--37.81K
--37.40K
--22.61K
--0.00
--0.00
Special income (expenses)
----
--0.00
--363.09K
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
----
--6.28K
--29.61K
--3.53K
----
----
----
----
----
----
----
----
----
----
----
Income before tax
23.21%-1.97M
52.30%-1.93M
-19.20%-1.69M
-85.83%-1.77M
-165.10%-2.56M
-446.13%-4.04M
-32.32%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-252.24%-739.59K
-483.12%-1.07M
---334.06K
---310.45K
---209.97K
---184.26K
Income tax
----
--0.00
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
Income after tax
23.21%-1.97M
52.30%-1.93M
-19.20%-1.69M
-85.83%-1.77M
-165.10%-2.56M
-446.13%-4.04M
-32.32%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-252.24%-739.59K
-483.12%-1.07M
---334.06K
---310.45K
---209.97K
---184.26K
Net income from continuous operations
23.21%-1.97M
52.30%-1.93M
-19.20%-1.69M
-85.83%-1.77M
-165.10%-2.56M
-446.13%-4.04M
-32.32%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-252.24%-739.59K
-483.12%-1.07M
---334.06K
---310.45K
---209.97K
---184.26K
Net income attributable to controlling interests
23.21%-1.97M
52.30%-1.93M
-19.20%-1.69M
-85.83%-1.77M
-165.10%-2.56M
-446.13%-4.04M
-32.32%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-252.24%-739.59K
-483.12%-1.07M
---334.06K
---310.45K
---209.97K
---184.26K
Net income attributable to common shareholders
23.21%-1.97M
52.30%-1.93M
-19.20%-1.69M
-85.83%-1.77M
-165.10%-2.56M
-446.13%-4.04M
-32.32%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-252.24%-739.59K
-483.12%-1.07M
---334.06K
---310.45K
---209.97K
---184.26K
Basic earnings per share
41.22%-0.32
54.43%-0.32
-18.68%-0.29
-85.63%-0.31
-225.93%-0.55
-446.15%-0.70
-32.32%-0.25
-185.39%-0.17
-211.33%-0.17
-252.18%-0.13
-483.10%-0.19
---0.06
---0.05
---0.04
---0.03
Diluted earnings per share
41.22%-0.32
54.43%-0.32
-18.68%-0.29
-85.63%-0.31
-225.93%-0.55
-446.15%-0.70
-32.32%-0.25
-185.39%-0.17
-211.33%-0.17
-252.18%-0.13
-483.10%-0.19
---0.06
---0.05
---0.04
---0.03
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
